» Articles » PMID: 20206072

Factors Contributing to Left Atrial Enlargement in Adults with Normal Left Ventricular Systolic Function

Overview
Journal J Cardiol
Publisher Elsevier
Date 2010 Mar 9
PMID 20206072
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Causes of left atrial (LA) enlargement and its gender difference in patients with normal left ventricular (LV) systolic function have not been clarified. We investigated the factors contributing to LA enlargement in patients with normal LV systolic function, addressing its gender difference.

Methods: We enrolled 380 patients (175 males and 205 females; mean age: 63 + or - 15 years) with LV ejection fraction > or = 50% who underwent Doppler echocardiography and blood tests at the same time as echocardiography. Patients with arrhythmias, significant valvular heart disease, and LV asynergy were excluded. The LA volume was measured by Simpson's method from apical 2- and 4-chamber views, and LA volume index (LAVI) was calculated as LA volume/body surface area. All patients, male and female were assigned to a group with a low or a high LAVI based on the median LAVI value, respectively.

Results: Age, female gender, hypertension, diabetes, hemoglobin concentration, LV mass index, Doppler parameters of LA contraction, and the ratio of mitral early diastolic velocity to early diastolic velocity of the mitral annulus (E/E') were significantly associated with a high LAVI in all patients. Multivariate analysis showed that LV mass index [odds ratio (OR) 1.05, 95% confidence interval (CI) 1.03-1.06, P<0.0001], hemoglobin concentration (OR 0.76, 95% CI 0.64-0.90, P<0.01), and female gender (OR 1.92, 95% CI 1.12-3.30, P<0.05) independently contributed to a high LAVI in all patients. In addition, LV mass index and hemoglobin concentration independently contributed to a high LAVI in both genders despite the absence of overt LV hypertrophy or anemia.

Conclusion: Increased LV wall thickness and decreased hemoglobin concentration might contribute to LA enlargement in patients with normal LV systolic function irrespective of gender.

Citing Articles

Patent Foramen Ovale and Other Cardiopathies as Causes of Embolic Stroke With Unknown Source.

Kim J J Stroke. 2024; 26(3):349-359.

PMID: 39396831 PMC: 11471358. DOI: 10.5853/jos.2024.02670.


A normal and particularly small (<35 mm) left atrial size measured during echocardiography suggests low likelihood of moderate or severe left ventricular systolic dysfunction.

Movahed M, Moghadam A Am J Cardiovasc Dis. 2024; 14(4):236-241.

PMID: 39309117 PMC: 11410789. DOI: 10.62347/YJTK3145.


Specific inflammatory profile of acute ischemic stroke patients with left atrial enlargement.

Fontaine J, Leboube S, Bochaton T, Thibault H, Amaz C, Cho T Front Cardiovasc Med. 2023; 10:1190857.

PMID: 37539088 PMC: 10394294. DOI: 10.3389/fcvm.2023.1190857.


Beneficial Effect of Edoxaban on Preventing Atrial Fibrillation and Coagulation by Reducing Inflammation HBG1/HBD Biomarkers.

Yang C, Wang X, Guo Y, Meng X, Li Y, Xia C Front Pharmacol. 2022; 13:904317.

PMID: 35721103 PMC: 9204214. DOI: 10.3389/fphar.2022.904317.


Joint efficacy of the three biomarkers SNCA, GYPB and HBG1 for atrial fibrillation and stroke: Analysis via the support vector machine neural network.

Wang X, Meng X, Meng L, Guo Y, Li Y, Yang C J Cell Mol Med. 2022; 26(7):2010-2022.

PMID: 35138035 PMC: 8980947. DOI: 10.1111/jcmm.17224.